ArticleInternational ophthalmology2026
Choroidal vascularization in polycystic ovary syndrome: an optical coherence tomography study.
Article in International ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Review
- Evaluation of Macular Thickness, Choroidal Thickness, and Choroidal Vascularity Index in Women With Polycystic Ovary Syndrome: A Cross-Sectional Study.Journal of ophthalmology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe aim of this study was to assess choroidal vascularization in individuals with new diagnoses of polycystic ovary syndrome(PCOS) using optical coherence tomography(OCT).
methodsThis prospective study included 46 patients with newly diagnosed PCOS and 40 healthy controls. Demographic and ocular examination characteristics of all participants were recorded. Retinal layers, choroidal thickness, and optic disc morphology (rim area, disc area, cup volume, and average and vertical cup/disc ratio) were assessed via OCT. High-line OCT sections were analyzed using the open-source image processing software ImageJ to determine luminal choroidal area (LCA),stromal choroidal area (SCA), and total choroidal area (TCA) in both macular(m) and peripapillary(p) regions. The ratio of LCA to TCA was defined as the choroidal vascularity index(CVI).The relationship between hormonal profile parameters (LH,FSH,TSH, estradiol, and prolactin) and choroidal vascular metrics was analyzed using multiple regression.
resultsThe two groups were matched for age and sex. Refractive error, axial length, body mass index, and intraocular pressure were comparable between groups(all p > 0.05). No statistically significant differences were found between groups in terms of retinal layers, choroidal thickness, or optic disc morphology parameters (all p > 0.05). Similarly, LCA, SCA, and TCA values did not significantly differ between groups(all p > 0.05). Although both macular CVI(mCVI) and peripapillary CVI(pCVI) values were higher in the PCOS group, the differences were not statistically significant (all p > 0.05). No significant correlations were found between hormonal parameters and choroidal vascular indices(all p > 0.05).
conclusionThis study is the first to evaluate choroidal vascularization in PCOS patients using OCT-based methods. Our findings indicate that choroidal vascular parameters, which provide direct insight into choroidal vascularization, are similar between PCOS patients and healthy controls.
Indexed as
Identifiers
41591539What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.